Scopolamine Trandermal System (Perrigo New York Inc)


Welcome to the PulseAid listing for the Scopolamine Trandermal System drug offered from Perrigo New York Inc. This Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Perrigo New York Inc
NON-PROPRIETARY NAME: scolopamine transdermal system
SUBSTANCE NAME: SCOPOLAMINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anticholinergic [EPC],Cholinergic Antagonists [MoA]
ROUTE: TRANSDERMAL
DOSAGE FORM: PATCH, EXTENDED RELEASE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-06-13
END MARKETING DATE: 0000-00-00


Scopolamine Trandermal System HUMAN PRESCRIPTION DRUG Details:

Item DescriptionScopolamine Trandermal System from Perrigo New York Inc
LABELER NAME: Perrigo New York Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/1)
START MARKETING DATE: 2017-06-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 45802-580_f910c1ab-1905-4881-ae76-e979387b19c4
PRODUCT NDC: 45802-580
APPLICATION NUMBER: ANDA078830

Other SCOPOLAMINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxter Healthcare CorporationTransderm Scop
Novatris Consumer Health, Inc.Transderm Scop
Perrigo New York IncScopolamine Trandermal System
Physicians Total Care, Inc.Transderm Scop
Sandoz IncTransderm Scop